Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Quanscient | $5,667,883 | (Nov 5, 2024)
OLIPOP PBC
United States
- Oakland, California
- 01/02/2022
- Series B
- $30,000,000
OLIPOP was founded in 2017 by Ben Goodwin and David Lester. Ben and David have been working together for nearly a decade to find accessible solutions to bring the benefits of digestive health to as many consumers as possible.
OLIPOP is a deliciously refreshing tonic that is crafted with prebiotics, botanicals and natural plant fiber to support your microbiome and benefit digestive health. We're on a mission to provide an affordable, delicious alternative to soda that delivers leading edge health benefits to mainstream consumers.
OLIPOP was created with the idea that diversity matters: in the food we eat, in our microbiome and in our communities. Our team is a group of diverse, community-minded individuals who are passionate about helping people from all walks of life make healthier decisions that will impact their overall wellness. We have an emphasis on high performance, growth mindset, authenticity, and having fun in what we do!
- Industry Food and Beverage Services
- Website https://drinkolipop.com/
- LinkedIn https://www.linkedin.com/company/olipop-pbc/
Related People
Ben GoodwinCo Founder
United States -
Santa Cruz, California,
I've been an entrepreneur and product developer in the health and wellness field for over a decade. In this capacity I’ve empowered other companies to realize their natural product visions and launched my own ventures.
My primary passion is to bridge the gap between niche/cutting-edge health trends and mainstream consumer needs. I’m extremely motivated to increase the impact and accessibility of products and companies in the health and wellness space.
I’ve built three different formulation and fermentation labs, worked closely with dozens of scientists and researchers and built three production facilities from scratch. I’ve formulated over 30 products from concept to commercialization and beyond, both independently and with a team.
Miros | $6,535,520 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Inquis Medical, Inc. | $40,000,000 | (Nov 5, 2024)
CrossBridge Bio | $10,000,000 | (Nov 5, 2024)